The proliferation and phenotypic expression of human osteoblasts on tantalum metal

Biomaterials

Volumn 25, Issue 12, 2004, Pages 2215-2227

  Findlay, David M ^a,b   Welldon, Katie ^a   Atkins, Gerald J ^a   Howie, Donald W ^a,b   Zannettino, Andrew C W ^c   Bobyn, Dennis ^d  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

^c INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^d MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Cell attachment and proliferation; Gene expression; Human osteoblasts; Mineralisation; Tantalum

Indexed keywords

BIOCOMPATIBILITY; CELLS; ORTHOPEDICS; PLASTICS; RNA; SURFACE PROPERTIES; TITANIUM;

HUMAN OSTEOBLASTS; PHENOTYPIC EXPRESSION;

TANTALUM;

COBALT; TANTALUM;

ARTICLE; BONE DEVELOPMENT; CELL COUNT; CELL DIVISION; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MINERALIZATION; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL;

EID: 0347130859     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2003.09.005     Document Type: Article

References (48)

1. Gronthos S., Graves S.E., Ohta S., Simmons P.J. The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. Blood. 84:1994;4164-4173.
2. Lian JB, Stein GS. Osteoblast biology. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. San Diego: Academic Press; 1996. p. 23-59.
3. Martin T.J., Ng K.W. Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity. J Cell Biochem. 56:1994;357-366.
4. Hofbauer L.C., Khosla S., Dunstan C.R., Lacey D.L., Boyle W.J., Riggs B.L. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res. 15:2000;2-12.
5. Yasuda H., Shima N., Nakagawa N., Mochizuki S.I., Yano K., Fujise N., Sato Y., Goto M., Yamaguchi K., Kuriyama M., Kanno T., Murakami A., Tsuda E., Morinaga T., Higashio K. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG). a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro Endocrinology. 139:1998;1329-1337.
6. Gronthos S., Zannettino A.C., Graves S.E., Ohta S., Hay S.J., Simmons P.J. Differential cell surface expression of the STRO-1 and alkaline phosphatase antigens on discrete developmental stages in primary cultures of human bone cells. J Bone Miner Res. 14:1999;47-56.
7. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., Sato M., Okamoto R., Kitamura Y., Yoshiki S., Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 89:1997;755-764.
8. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., Stamp G.W., Beddington R.S., Mundlos S., Olsen B.R., Selby P.B., Owen M.J. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 89:1997;765-771.
9. Takeuchi Y., Watanabe S., Ishii G., Takeda S., Nakayama K., Fukumoto S., Kaneta Y., Inoue D., Matsumoto T., Harigaya K., Fujita T. Interleukin-11 as a stimulatory factor for bone formation prevents bone loss with advancing age in mice. J Biol Chem. 277:2002;49011-49018.
10. Shaughnessy S.G., Walton K.J., Deschamps P., Butcher M., Beaudin S.M. Neutralization of interleukin-11 activity decreases osteoclast formation and increases cancellous bone volume in ovariectomized mice. Cytokine. 20:2002;78-85.
11. Adams J.C., Watt F.M. Regulation of development and differentiation by the extracellular matrix. Development. 117:1993;1183-1198.
12. Traianedes K., Ng K.W., Martin T.J., Findlay D.M. Cell substratum modulates responses of preosteoblasts to retinoic acid. J Cell Physiol. 157:1993;243-252.
13. Southey M.C., Findlay D.M., Kemp B.E. Regulation of membrane-associated tyrosine phosphatases in UMR 106.06 osteoblast-like cells. Biochem J. 305:1995;485-490.
14. Traianedes K., Findlay D.M., Martin T.J., Gillespie M.T. Modulation of the signal recognition particle 54-kDa subunit (SRP54) in rat preosteoblasts by the extracellular matrix. J Biol Chem. 270:1995;20891-20894.
15. Traianedes K., Martin T.J., Findlay D.M. Regulation of osteopontin expression by type I collagen in preosteoblastic UMR201 cells. Connect Tissue Res. 34:1996;63-74.
16. Celic S., Chilco P.J., Zajac J.D., Martin T.J., Findlay D.M. A type I collagen substrate increases PTH/PTHrP receptor mRNA expression and suppresses PTHrP mRNA expression in UMR106-06 osteoblast-like cells. J Endocrinol. 150:1996;299-308.
17. Zreiqat H., Howlett C.R. Titanium substrata composition influences osteoblastic phenotype. in vitro study J Biomed Mater Res. 47:1999;360-366.
18. Zreiqat H., Evans P., Howlett C.R. Effect of surface chemical modification of bioceramic on phenotype of human bone-derived cells. J Biomed Mater Res. 44:1999;389-396.
19. Bobyn J.D., Stackpool G.J., Hacking S.A., Tanzer M., Krygier J.J. Characteristics of bone ingrowth and interface mechanics of a new porous tantalum biomaterial. J Bone Jt Surg Br. 81:1999;907-914.
20. Bobyn J.D., Toh K.K., Hacking S.A., Tanzer M., Krygier J.J. Tissue response to porous tantalum acetabular cups. a canine model J Arthroplasty. 14:1999;347-354.
21. Hacking S.A., Bobyn J.D., Toh K., Tanzer M., Krygier J.J. Fibrous tissue ingrowth and attachment to porous tantalum. J Biomed Mater Res. 52:2000;631-638.
22. Hogan M.E., Degaetano D.H., Klomparens K.L. Effects of substrate texture and curvature on the morphology of cultured cells. J Electron Microsc Technol. 18:1991;106-116.
23. Hacking S.A., Tanzer M., Harvey E.J., Krygier J.J., Bobyn J.D. Relative contributions of chemistry and topography to the osseointegration of hydroxyapatite coatings. Clin Orthop. 405:2002;24-38.
24. Evdokiou A., Bouralexis S., Atkins G.J., Chai F., Hay S., Clayer M., Findlay D.M. Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis. Int J Cancer. 99:2002;491-504.
25. Lyons AB, Hasbold J, Hodgkin PD. Flow cytometric analysis of cell division history using dilution of carboxyfluorescein diacetate succinimidyl ester, a stably integrated fluorescent probe. In: Methods in cell biology, vol. 63. New York: Academic Press; 2001.
26. Atkins GJ, Kostakis P, Pan B, Farrugia A, Gronthos S, Evdokiou A, Harrison K, Findaly DM. Zannettino ACW: RANKL expression is related to the differentiation state of human osteoblasts. J Bone Miner Res 2003;89:206-14.
27. Atkins G.J., Haynes D.R., Graves S.E., Evdokiou A., Hay S., Bouralexis S., Findlay D.M. Expression of osteoclast differentiation signals by stromal elements of giant cell tumors. J Bone Miner Res. 15:2000;640-649.
28. Cohen R. A porous tantalum trabecular metal. basic science Am J Orthop. 31:2002;216-217.
29. Matsuno H., Yokoyama A., Watari F., Uo M., Kawasaki T. Biocompatibility and osteogenesis of refractory metal implants, titanium, hafnium, niobium, tantalum and rhenium. Biomaterials. 22:2001;1253-1262.
30. Puleo D.A., Holleran L.A., Doremus R.H., Bizios R. Osteoblast responses to orthopedic implant materials in vitro. J Biomed Mater Res. 25:1991;711-723.
31. Keller J.C., Stanford C.M., Wightman J.P., Draughn R.A., Zaharias R. Characterizations of titanium implant surfaces. III. J Biomed Mater Res. 28:1994;939-946.
32. Spyrou P., Papaioannou S., Hampson G., Brady K., Palmer R.M., McDonald F. Cytokine release by osteoblast-like cells cultured on implant discs of varying alloy compositions. Clin Oral Implants Res. 13:2002;623-630.
33. Hendrich C., Noth U., Stahl U., Merklein F., Rader C.P., Schutze N., Thull R., Tuan R.S., Eulert J. Testing of skeletal implant surfaces with human fetal osteoblasts. Clin Orthop. 394:2002;278-289.
34. Bigerelle M., Anselme K., Noel B., Ruderman I., Hardouin P., Iost A. Improvement in the morphology of Ti-based surfaces. a new process to increase in vitro human osteoblast response Biomaterials. 23:2002;1563-1577.
35. Bowers K.T., Keller J.C., Randolph B.A., Wick D.G., Michaels C.M. Optimization of surface micromorphology for enhanced osteoblast responses in vitro. Int J Oral Maxillofac Implants. 7:1992;302-310.
36. Groessner-Schreiber B., Tuan R.S. Enhanced extracellular matrix production and mineralization by osteoblasts cultured on titanium surfaces in vitro. J Cell Sci. 101:1992;209-217.
37. Keller J.C. Tissue compatibility to different surfaces of dental implants. in vitro studies Implant Dent. 7:1998;331-337.
38. Kieswetter K., Schwartz Z., Hummert T.W., Cochran D.L., Simpson J., Dean D.D., Boyan B.D. Surface roughness modulates the local production of growth factors and cytokines by osteoblast-like MG-63 cells. J Biomed Mater Res. 32:1996;55-63.
39. Schwartz Z., Lohmann C.H., Sisk M., Cochran D.L., Sylvia V.L., Simpson J., Dean D.D., Boyan B.D. Local factor production by MG63 osteoblast-like cells in response to surface roughness and 1,25-(OH)2D3 is mediated via protein kinase C- and protein kinase A-dependent pathways. Biomaterials. 22:2001;731-741.
40. Gehron Robey P, Boskey AL. The biochemistry of bone. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. San Diego: Academic Press; 1996. p. 23-59.
41. Schmidt C., Kaspar D., Sarkar M.R., Claes L.E., Ignatius A.A. A scanning electron microscopy study of human osteoblast morphology on five orthopedic metals. J Biomed Mater Res. 63:2002;252-261.
42. Anselme K., Bigerelle M., Noel B., Iost A., Hardouin P. Effect of grooved titanium substratum on human osteoblastic cell growth. J Biomed Mater Res. 60:2002;529-540.
43. Lauer G., Wiedmann-Al-Ahmad M., Otten J.E., Hubner U., Schmelzeisen R., Schilli W. The titanium surface texture effects adherence and growth of human gingival keratinocytes and human maxillar osteoblast-like cells in vitro. Biomaterials. 22:2001;2799-2809.
44. Rogers S.D., Howie D.W., Graves S.E., Pearcy M.J., Haynes D.R. In vitro human monocyte response to wear particles of titanium alloy containing vanadium or niobium. J Bone Jt Surg Br. 79:1997;311-315.
45. Sakai T., Takeda S., Nakamura M. The effects of particulate metals on cell viability of osteoblast-like cells in vitro. Dent Mater J. 21:2002;133-146.
46. Haynes D.R., Hay S.J., Rogers S.D., Ohta S., Howie D.W., Graves S.E. Regulation of bone cells by particle-activated mononuclear phagocytes. J Bone Jt Surg Br. 79:1997;988-994.
47. Willert H.G., Buchhorn G.H., Hess T. The significance of wear and material fatigue in loosening of hip prostheses. Orthopade. 18:1989;350-369.
48. Howie D.W. Tissue response in relation to type of wear particles around failed hip arthroplasties. J Arthroplasty. 5:1990;337-348.